Lopez-Beltran, A.; López-Rios, F.; Montironi, R.; Wildsmith, S.; Eckstein, M.
Immune Checkpoint Inhibitors in Urothelial Carcinoma: Recommendations for Practical Approaches to PD-L1 and Other Potential Predictive Biomarker Testing. Cancers 2021, 13, 1424.
https://doi.org/10.3390/cancers13061424
AMA Style
Lopez-Beltran A, López-Rios F, Montironi R, Wildsmith S, Eckstein M.
Immune Checkpoint Inhibitors in Urothelial Carcinoma: Recommendations for Practical Approaches to PD-L1 and Other Potential Predictive Biomarker Testing. Cancers. 2021; 13(6):1424.
https://doi.org/10.3390/cancers13061424
Chicago/Turabian Style
Lopez-Beltran, Antonio, Fernando López-Rios, Rodolfo Montironi, Sophie Wildsmith, and Markus Eckstein.
2021. "Immune Checkpoint Inhibitors in Urothelial Carcinoma: Recommendations for Practical Approaches to PD-L1 and Other Potential Predictive Biomarker Testing" Cancers 13, no. 6: 1424.
https://doi.org/10.3390/cancers13061424
APA Style
Lopez-Beltran, A., López-Rios, F., Montironi, R., Wildsmith, S., & Eckstein, M.
(2021). Immune Checkpoint Inhibitors in Urothelial Carcinoma: Recommendations for Practical Approaches to PD-L1 and Other Potential Predictive Biomarker Testing. Cancers, 13(6), 1424.
https://doi.org/10.3390/cancers13061424